Computational design for the development of natural molecules as compelling inhibitors against the target SARS-CoV-2: An in-silico attempt

Q2 Pharmacology, Toxicology and Pharmaceutics

journal of applied pharmaceutical science Pub Date : 2023-01-01 DOI:10.7324/japs.2023.134301

Nagarjuna Palathoti, Kalirajan Rajagopal, Gowramma Byran, Kannan Raman, Edwin Jose, Manikandan Gurunathan

引用次数: 0

Abstract

New benzimidazole derivatives as inhibitors of Pteridine reductase 1: Design, molecular docking study and ADMET predictionShraddha Phadke, Rakesh Somani, Devender Pathak

查看原文本刊更多论文

开发天然分子作为靶向SARS-CoV-2的引人注目的抑制剂的计算设计:计算机尝试

新的苯并咪唑衍生物作为蝶啶还原酶1的抑制剂:设计、分子对接研究和ADMET预测

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

journal of applied pharmaceutical science Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)

CiteScore

2.20

自引率

0.00%

发文量

224

期刊介绍： Journal of Applied Pharmaceutical Science (JAPS) is a monthly, international, open access, journal dedicated to various disciplines of pharmaceutical and allied sciences. JAPS publishes manuscripts (Original research and review articles Mini-reviews, Short communication) on original work, either experimental or theoretical in the following areas; Pharmaceutics & Biopharmaceutics Novel & Targeted Drug Delivery Nanotechnology & Nanomedicine Pharmaceutical Chemistry Pharmacognosy & Ethnobotany Phytochemistry Pharmacology & Toxicology Pharmaceutical Biotechnology & Microbiology Pharmacy practice & Hospital Pharmacy Pharmacogenomics Pharmacovigilance Natural Product Research Drug Regulatory Affairs Case Study & Full clinical trials Biomaterials & Bioactive polymers Analytical Chemistry Physical Pharmacy.